EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Onset of efficacy and adverse events during Cenobamate titration period

Bernhard J Steinhoff iD, Elinor Ben-Menachem, Christian Brandt, Irene García Morales, William E Rosenfeld, Estevo Santamarina, José M Serratosa

Acta Neurologica Scandinavica · 2022-09 · 146 (3) · 265-275

DOI: 10.1111/ane.13659 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 16.06.2022. Verfasst von Bernhard J Steinhoff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department for Adults, Kork Epilepsy Center, Kehl-Kork, Germany. Hauptthemen laut MEDLINE: Epilepsies, Partial. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Angelini S.p.a..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, PartialAdultAnticonvulsantsCarbamatesChlorophenolsDrug Therapy, CombinationHumansQuality of LifeSeizuresTetrazolesTreatment Outcome

Stichwörter der Autor:innen

anticonvulsantscenobamateclinical trialdouble-blind methoddrug therapy, combinationdrug-related side effects and adverse reactionsdrug-resistant epilepsyseizures

Substanzen

AnticonvulsantsCarbamatesChlorophenolsTetrazolesCenobamate

Autor:innen und Institutionen

  • Department for Adults, Kork Epilepsy Center, Kehl-Kork, Germany.
  • Department of Neurology and Clinical Neurophysiology and Medical Faculty, University of Freiburg, Freiburg, Germany.
  • Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
  • Department of General Epileptology, Bethel Epilepsy Centre, Mara Hospital, University Hospital for Epileptology, Bielefeld, Germany.
  • Servicio de Neurología, Programa de Epilepsia, Hospital Ruber Internacional, Madrid, Spain.
  • Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, Missouri, USA.

ORCID-Profile: Bernhard J Steinhoff

Förderung

  • Angelini S.p.a.

Zitieren

APA

Steinhoff, B. J., Ben-Menachem, E., Brandt, C., García Morales, I., Rosenfeld, W. E., Santamarina, E., & Serratosa, J. M. (2022). Onset of efficacy and adverse events during Cenobamate titration period. Acta Neurologica Scandinavica, 146(3), 265-275. https://doi.org/10.1111/ane.13659

Vancouver

Steinhoff BJ, Ben-Menachem E, Brandt C, García Morales I, Rosenfeld WE, Santamarina E, et al. Onset of efficacy and adverse events during Cenobamate titration period. Acta Neurologica Scandinavica. 2022;146(3):265-275. doi:10.1111/ane.13659

BibTeX
@article{Steinhoff2022,
  author = {Steinhoff, Bernhard J and Ben-Menachem, Elinor and Brandt, Christian and García Morales, Irene and Rosenfeld, William E and Santamarina, Estevo and Serratosa, José M},
  title = {Onset of efficacy and adverse events during Cenobamate titration period},
  journal = {Acta Neurologica Scandinavica},
  year = {2022},
  volume = {146},
  number = {3},
  pages = {265--275},
  doi = {10.1111/ane.13659}
}
Kostenlos starten →